MICHAEL H. BISON

Michael Bison, a partner in the firm’s Technology Companies Group and member of the firm’s Life Sciences, Clean Tech and Capital Markets Practices, specializes in representing public and privately held life science, clean technology and high technology companies, as well as the venture capital and private equity firms and investment banks that focus on those industries. Mr. Bison represents companies in all stages of development, from start-up through initial public offering or acquisition.

WORK FOR CLIENTS

Mr. Bison regularly counsels his clients on general corporate and corporate finance matters, including venture capital transactions, public offerings of equity and debt, mergers and acquisitions, SEC compliance and corporate governance. He also regularly advises his clients on technology acquisitions, licensing, joint-ventures and strategic alliances. In addition, Mr. Bison spends a significant amount of time working with early stage and start-up companies assisting them with formation, seed financing and intellectual property protection.

Mr. Bison also represents venture capital and private equity investors in connection with the making and monitoring of portfolio investments in the life sciences, clean technology and high technology sectors. He has represented numerous investment banks and financial advisors in connection with private placements of equity and debt, including PIPES transactions, and underwritten offerings.

A significant portion of Mr. Bison’s practice includes the representation of issuers and investors in connection with cross-border financings and commercial transactions, and in connection with the ongoing U.S. operations of these clients.

PROFESSIONAL ACTIVITIES

Mr. Bison is a member, through the firm, of the Biotechnology Industry Organization (BIO), Massachusetts Biotechnology Council (MBC), MassMEDIC and the Medical Development Group (MDG). He is also a member of the American and Boston Bar Associations.

MEDIA

Mr. Bison has published a variety of articles on venture capital and related topics, including:

• “Massachusetts Life Sciences Center Launches New Tax Incentive and Early-Stage Investment Programs,” Goodwin Procter Client Alert (January 2009)
• “Rethinking Cash-Management and Investment Policies,” Financial Executive Magazine (September 2008)
• “Turbulent Credit Markets Require Carefully Crafted Cash Management Policies,” Goodwin Procter Client Alert (March 2008)
• “U.S. House Passes Legislation to Enable Venture-Backed Companies to Qualify for Federal Grants,” Goodwin Procter Client Alert (October 2007)
• “Biotech Companies Must Get Creative As They Seek Alternative Paths to Access Public Markets,” BioNews (October/November 2006)

PROFESSIONAL EXPERIENCE

Prior to joining Goodwin Procter, Mr. Bison was a member of the Business Practice Group at Testa, Hurwitz & Thibeault, LLP in Boston. Prior to beginning his legal career, he was a business and information systems consultant at Andersen Consulting, LLP (now Accenture Ltd.).

BAR AND COURT ADMISSIONS

Mr. Bison is admitted to practice in Massachusetts.

RECOGNITION

Mr. Bison has been selected for inclusion in The Legal 500 and was recognized as a Massachusetts Super Lawyer “Rising Star” by Law & Politics and Boston magazines.